Disease · HP_0002829
Trials15
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 2 more are not shown, since the checks do not confirm them.
1 to 15 of 15
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02728752 | Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy) | Phase 3 | 95 | 2021-04-21 | Dermatomyositis | HUMAN IMMUNOGLOBULIN G | Its record names the disease | ClinicalTrials.gov |
| NCT01651806 | Weighted Versus Uniform Dose of Tranexamic Acid in Patients Undergoing Primary, Knee Arthroplasty | Phase 2/3 | 65 | 2017-12-13 | Osteoarthritis, Intraoperative Bleeding | TRANEXAMIC ACID | Its record names the disease | ClinicalTrials.gov |
| NCT00372333 | IDEA-033 Open Label Study | Phase 3 | 491 | Joint Pain, Musculoskeletal Pain, Stiffness, Soft Tissue Inflammation in Designated Target Area(s) | KETOPROFEN | Its record names the disease | ClinicalTrials.gov | |
| NCT01373697 | Study to Assess the Efficacy and Safety of Ibuprofen 50 mg/g Gel Compared to Profenid 25mg/g Gel | Phase 3 | 144 | Muscular Atrophy, Sprains, Tendonitis | IBUPROFEN | Its record names the disease | ClinicalTrials.gov | |
| NCT04408560 | Evaluation of the Efficacy of a Homeopathic Protocol in Patients With Non-metastatic Breast Cancer | Not applicable | 140 | Breast Cancer Female, Joint Pain | POISON OAK EXTRACT | Its record names the disease | ClinicalTrials.gov | |
| NCT02778906 | Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia | Phase 3 | 98 | Arthralgia, Arthritis | ABATACEPT | Its record names the disease | ClinicalTrials.gov | |
| NCT07254637 | Tocilizumab in Chronic Inflammatory CPPD Disease | Phase 2 | 80 | Calcium Pyrophosphate Deposition Disease | TOCILIZUMAB | Its record names the disease | ClinicalTrials.gov | |
| NCT04511832 | Comparative Effectiveness of Acupuncture and Nonsteroidal Anti-inflammatory Drugs for the Management of Aromatase Inhibitor Induced Arthralgia Among Breast Cancer Survivors | Not applicable | 54 | Breast Cancer | DICLOFENAC | Its record names the disease | ClinicalTrials.gov | |
| NCT04354649 | Immune-Mediated Pathophysiology And Clinical Triage Program | Phase 2 | 46 | Arthritis, Arthralgia | HYDROXYCHLOROQUINE, PREDNISONE | Its record names the disease | ClinicalTrials.gov | |
| NCT00211718 | Intra-Articular Injection of Botulinum Toxin Type A for Shoulder Pain | Phase 3 | 40 | Arthritis, Shoulder Pain | BOTULINUM TOXIN TYPE A | Its record names the disease | ClinicalTrials.gov | |
| NCT02024568 | Exploratory Study on the Use of Pregabalin for the Treatment of Taxol Related Arthralgia-Myalgia | Phase 2 | 38 | Taxane, Drug-related Side Effects and Adverse Reactions, Pain, Breast Cancer | PREGABALIN | Its record names the disease | ClinicalTrials.gov | |
| NCT06538389 | High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer | Phase 2 | 36 | Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Breast Adenocarcinoma, Breast Ductal Carcinoma In Situ, Estrogen Receptor-Positive Breast Carcinoma, Progesterone Receptor-Positive Breast Carcinoma | CANNABIDIOL | Its record names the disease | ClinicalTrials.gov | |
| NCT07479693 | Comparison of Hyaluronic Acid, Injectable Platelet-Rich Fibrin, and Prolotherapy in TMJ Arthrocentesis | Not applicable | 36 | Temporomandibular Joint Pain, Arthrocentesis | DEXTROSE, HYALURONIC ACID | Its record names the disease | ClinicalTrials.gov | |
| NCT02263638 | Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study | Phase 2 | 17 | Refractory Hemochromatosis Rheumatism | ANAKINRA | Its record names the disease | ClinicalTrials.gov | |
| NCT00045812 | SCH-58235 (Ezetimibe) to Treat Homozygous Sitosterolemia | Phase 2 | 5 | Lipoidosis | EZETIMIBE | Its record names the disease | ClinicalTrials.gov |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/HP_0002829/trials